TITLE

Antibodies to Human T-Lymphotropic Virus Type III and Development of the Acquired Immunodeficiency Syndrome in Homosexual Men Presenting with Immune Thrombocytopenia

AUTHOR(S)
Abrams, Donald I.; Kiprov, Dobri D.; Goedert, James J.; Sarngadharan, M.G.; Gallo, Robert C.; Volberding, Paul A.
PUB. DATE
January 1986
SOURCE
Annals of Internal Medicine;Jan86, Vol. 104 Issue 1, p47
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents information on a study which examined seropositivity for antibodies to the causative retrovirus and the progression in patients of isolated thrombocytopenia to overt AIDS. Methods; Results; Discussion.
ACCESSION #
7002450

 

Related Articles

  • Exacerbated signs of an immunosuppressive AIDS-like disease in macaques infected with multiple retroviruses. Mitchell, Jane L.; Hood, Simon; Auda, Ghazi; Almond, Neil M.; Rose, Nicola J. // Retrovirology;Jan2011 Supplement 1, Vol. 8, pA207 

    An abstract of the research paper titled,"Exacerbated signs of an immunosuppressive AIDS-like disease in macaques infected with multiple retroviruses," is presented.

  • Updated HIV Treatment Recommendations for 2002.  // American Family Physician;12/1/2002, Vol. 66 Issue 11, p2159 

    Discusses the study 'Antiretroviral treatment for adult HIV infection in 2002. Updated recommendations of the International AIDS Society-USA Panel,' by P.G. Yeni et al., from the July 10, 2002 issue of the 'Journal of American Medical Association.'

  • The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Sheehy, Ann M.; Gaddis, Nathan C.; Malim, Michael H. // Nature Medicine;Nov2003, Vol. 9 Issue 11, p1404 

    The human protein apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like-3G (APOBEC3G), also known as CEM-15, mediates a newly described form of innate resistance to retroviral infection by catalyzing the deamination of deoxycytidine to deoxyuridine in viral cDNA replication...

  • Weight Gain, Improvement in Metabolic Profile, and CD4 Count with Insulin Administration in an AIDS Patient. Kabadi, Udaya M. // AIDS Patient Care & STDs;Nov2000, Vol. 14 Issue 11, p575 

    Assesses the effect of subcutaneous (S.C.) insulin administration in conjunction with antiretroviral drug therapy in a subject with AIDS. Limited success of anabolic agents utilized for retarding or preventing progressive wasting of patients; Marked improvements in patients treated with S.C....

  • Body Habitus Alterations in HIV-Infected Women Treated with Combined Antiretroviral Therapy. Ridolfo, Anna Lisa; Gervasoni, Cristina; Bini, Teresa; Galli, Massimo // AIDS Patient Care & STDs;Nov2000, Vol. 14 Issue 11, p595 

    Fat distribution alterations are among the most frequent and unexpected side effects of combined antiretroviral therapy. They may occur in patients receiving protease inhibitor-containing regimens and those treated with combinations of only nucleoside reverse transcriptase inhibitors. The broad...

  • A mixed report card.  // Advocate;03/16/99, Issue 781, p13 

    Reports on the holding of the 1999 Conference on Retrovirus and Opportunistic Infections in Chicago, Illinois. Growing rate of drug failure among patients; Viral strains' growing resistant to drugs; Strong potential of several drugs.

  • Antiretroviral therapy is only part of it. Mbewu, Anthony // Bulletin of the World Health Organization;2001, Vol. 79 Issue 12, p1152 

    Focuses on the use of antiretroviral therapy in the prevention of AIDS in the developing countries. Efficacy of retroviral therapy in improving the quality of life; Diagnosis and selection of patients for treatment; Comparison between highly active antiretroviral therapy and directly observed...

  • HIV/AIDS 2001: Latest treatment strategies. Brown, Billy Ray; Robinson, Marvin // Drug Topics;3/19/2001, Vol. 145 Issue 6, p39 

    Presents updates on the development of treatment strategies for AIDS/HIV in 2001. Classes of antiretrovirals approved by the United States Food and Drug Administration; Study which determined the role of adherence to virologic failures in the majority of patients; Lipid management in HIV.

  • Porous metal—organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. Horcajada, Patricia; Chalati, Tamim; Serre, Christian; Gillet, Brigitte; Sebrie, Catherine; Baati, Tarek; Eubank, Jarrod F.; Heurtaux, Daniela; Clayette, Pascal; Kreuz, Christine; Chang, Jong-San; Hwang, Young Kyu; Marsaud, Veronique; Bories, Phuong-Nhi; Cynober, Luc; Gil, Sophie; Férey, Gérard; Couvreur, Patrick; Gref, Ruxandra // Nature Materials;Feb2010, Vol. 9 Issue 2, p172 

    In the domain of health, one important challenge is the efficient delivery of drugs in the body using non-toxic nanocarriers. Most of the existing carrier materials show poor drug loading (usually less than 5 wt% of the transported drug versus the carrier material) and/or rapid release of the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics